10
Loading video...

By Daniella Gray
Reporter
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Scientists have put decades of research on Type 2 diabetes and Alzheimer’s disease under the microscope, revealing a striking link between the two conditions.
A systematic review and meta-analysis, published in Alzheimer's Research and Therapy, brought together 40 observational studies, covering more than 27 million data points.
Researchers from Curtin University, Perth, Australia, found that people with Type 2 diabetes were 53 percent more likely to develop Alzheimer’s than those without diabetes.
Read More on Health
"It doesn't mean that someone with Type 2 diabetes has a 53 percent chance of developing Alzheimer's disease," Emmanuel Adewuyi, an NHMRC Investigator Fellow at the Curtin School of Population Health and one of the study's authors, told Newsweek. "Nor does it mean that Type 2 diabetes causes Alzheimer's disease, as these are observational studies that cannot establish causation."

...
Adewuyi said individual risk depends on factors including age, genetics and overall health.
"The findings should therefore not be interpreted as meaning that Alzheimer's disease is inevitable for people with type 2 diabetes," he said.
The review was deliberately restricted to research specifically addressing Type 2 diabetes and Alzheimer's.
Earlier analyses have often combined multiple forms of diabetes or different types of dementia.
The study authors also said several biological mechanisms could potentially help explain the association, including insulin resistance, chronic high blood sugar, oxidative stress and inflammation.
Pallabi Sanyal-Dey, an internal medicine physician who was not involved in the research, told Newsweek the relative-risk figure "sounds alarming" but does not predict what will happen to an individual.
"What this study adds is the absolute number," Sanyal-Dey said. "Pooling 40 studies, the authors found about five new Alzheimer’s cases per 1,000 people with Type 2 diabetes each year. Over 10 years, that is roughly 5 in 100, so about 95 in 100 are not diagnosed in that window."
There are also important limitations. The included studies were observational, while estimates varied substantially between studies.
The researchers consequently rated the certainty of evidence for both the pooled incidence and relative-risk findings as "very low."
For people with Type 2 diabetes, Adewuyi said the review did not test whether particular interventions prevent Alzheimer's.
He advised people with Type 2 diabetes to keep working with their healthcare team to manage the condition in a way that works for them.
"This includes managing blood glucose and blood pressure, remaining physically active where possible, avoiding smoking, and addressing other cardiovascular risk factors," Adewuyi said. "These measures have well-established benefits for overall health."
An important takeaway, he said, is that Alzheimer’s and Type 2 diabetes are becoming increasingly pressing health challenges as populations age.
"Understanding how often Alzheimer’s disease occurs among people with Type 2 diabetes helps inform future research, healthcare planning and efforts to better understand the factors that contribute to dementia risk," Adewuyi said.
Reference
Nguyen, T. T. H., et al. (2026). Incidence and risk of Alzheimer's disease in individuals with type 2 diabetes: A systematic review and meta-analysis. Alzheimer’s Research & Therapy. https://link.springer.com/article/10.1186/s13195-026-02254-7
Contact Newsweek editors on this story: Kara Dolman and Tony Phillips.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines